Literature DB >> 6148958

Quantification of side-effects of beta-adrenoceptor blockers using visual analogue scales.

R V Lewis, P R Jackson, L E Ramsay.   

Abstract

We have devised a series of visual analogue scales (VAS) to measure the side-effects prevalent amongst hypertensive patients taking beta-adrenoceptor blockers, and we present the results of a pilot study. These show that the method is suitable for studying side-effects and suggest that patients on beta-adrenoceptor blockers experience a greater incidence of tiredness of the legs, (P = 0.001), cold digits (P = 0.005) and vivid dreaming (P = 0.01) when compared to hypertensive patients not taking beta-adrenoceptor blockers.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6148958      PMCID： PMC1463646          DOI： 10.1111/j.1365-2125.1984.tb02471.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  3 in total

1.  Nature and incidence of unwanted effects with atenolol.

Authors:  W T Simpson
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

2.  Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment.

Authors:  C Maxwell
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

Review 3.  Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.

Authors:  M J Kendall; L Beeley
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310
  3 in total
  11 in total

1.  Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.

Authors:  R V Lewis; L E Ramsay; P R Jackson; W W Yeo; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

2.  CNS-related subjective symptoms during treatment with beta 1-adrenoceptor antagonists (atenolol, metoprolol): two double-blind placebo controlled studies.

Authors:  E Dimenäs; C Dahlöf; B Olofsson; I Wiklund
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

3.  Documentation of an instrument for assessment of subjective CNS-related symptoms during cardiovascular pharmacotherapy.

Authors:  C Dahlöf; E Dimenäs; B Olofsson
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

4.  Side-effects of beta-adrenoceptor blocking drugs assessed by visual analogue scales.

Authors:  R V Lewis; P R Jackson; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

Review 5.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

6.  Measuring side-effects of beta-adrenoceptor antagonists: a comparison of two methods.

Authors:  R V Lewis; P R Jackson; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

7.  Chronic beta-blockade does not influence muscle power output during high-intensity exercise of short-duration.

Authors:  W E Derman; F Dunbar; M Haus; M Lambert; T D Noakes
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1993

8.  The effect of a week's beta-adrenoceptor antagonism on daytime heart-rates, subjective responses to exercise, and physical activity in normal subjects.

Authors:  J M Patrick; H J Wharrad; C G Wilson; A T Birmingham
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

9.  Absence of excess peripheral muscle fatigue during beta-adrenoceptor blockade.

Authors:  R G Cooper; M J Stokes; R H Edwards; R D Stark
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

Review 10.  Adverse reactions with beta-adrenoceptor blocking drugs. An update.

Authors:  R V Lewis; C Lofthouse
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.